We are currently facing an issue in receiving the NSE feed. Hence the stock prices are not updated. We are working on fixing this at the earliest. We regret the inconvenience caused.

Sensex Opens Strong; Yes Bank Continues to Rally

Fri, 25 Jan 09:30 am

   Previous Close   

   Pre-Open   

   12:30 pm   

   Closing   

   Podcast   

Asian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.4% while the Hang Seng is up 1.2%. The Nikkei 225 is trading up by 1%. Meanwhile, the S&P 500 edged higher but the Dow closed nominally lower on Thursday as lingering anxieties about slowing global growth and unresolved trade disputes undercut a spate of strong earnings, while chipmakers rallied to give the Nasdaq a solid gain.

Back home, India share markets opened on a strong note. The BSE Sensex is trading up by 223 points while the NSE Nifty is trading up by 59 points. Both, the BSE Mid Cap index and BSE Small Cap index opened up by 0.2%.

All sectoral indices have opened the day in green with and witnessing maximum buying interest.

Speaking of an interesting development in stock markets, the growing participation in the Indian stock markets has resulted in not just money flowing into mutual funds, but also in the opening of demat accounts.

Direct Participation in Stock Markets is Growing Steadily

In fact, the attractiveness of Indian equities and the fact that investing in demat accounts is now very easy has led to a steady rise in accounts.

What more, this trend is all set to continue, as the Indian stock markets scale new highs in the coming years.

Moving on, the rupee is currently trading at Rs 70.98 against the US$.

Yes bank share price rallied over 10% in the early trade on the news that Ravneet Singh Gill will take over as CEO of Yes Bank on March 1, succeeding cofounder Rana Kapoor.

In the news from the economy. As per an article in a leading financial daily, the tariff war between the US and China is benefitting India as its exports to the neighbouring country have increased by about 32% to US$8.5 billion during the June-November 2018 period.

Exports to China had stood at US$6.37 billion in June-November 2017.

In June and September 2018, the US announced high customs duties on several Chinese goods. In retaliation, China also raised levies on American goods.

As per Federation of Indian Export Organisations (FIEO), India's exports to the US grew by 12%.

Reportedly, commodities that have exhibited high growth during the period to China include petroleum products, chemicals, cotton yarn, plastic raw material, and marine products.

While tariff war is not good for the global trade, the same has come as an opportunity for other countries including India. India's exports to China in June-November 2018 went up by 32% and to US by 12% in the same period, the reports noted.

If the tariff escalation continues, India has to increase production capabilities to meet the growing demand in both the markets.

Growth in exports to China is beneficial for India as it has huge trade deficit with the neighbouring country.

Trade deficit with China increased to US$63.1 billion in 2017-18 from US$51.1 billion in 2016-17.

India is taking several steps to promote shipments to China. Recently it has managed to export agricultural goods such as non-basmati rice to China.

Moving on to the news from the pharma sector. As per an article in a leading financial daily, Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Derma-Smoothe Topical Oil.

It is used in the treatment of scalp psoriasis.

As per IQVIA sales data, for the 12 months to September 2018, DermaSmoothe/FS Topical Oil, 0.01% (scalp oil), achieved annual sales of around US$ 14 million.

The company's current portfolio consists of 141 products authorised for distribution at the US marketplace and 58 Abbreviated New Drug Applications (ANDAs) pending approval with the USFDA.

To know more about the company, you can access to Glenmark Pharma's latest result analysis and Glenmark Pharma's Stock Analysis on our website.

Glenmark Pharma share price opened up by 0.9%.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapBSE Basic MaterialsBSE Consumer DiscretionaryBSE IndustrialsBSE UtilitiesBSE Sensex 50BSE Sensex Next 50BSE Bharat 22BSE 150 MidCapBSE 250 SmallCapBSE 250 LargeMidCapBSE 400 MidSmallCapBSE AllCapBSE LargeCapBSE SmallCap SelectBSE 100 LargeCap TMCBSE InfraBSE ManufacturingBSE CPSEBSE Private BankBSE Diversified FinancialsBSE MomentumBSE Low VolatilityBSE QualityBSE Enhanced ValueBSE Divident StabilityS&P BSE IPOBSE SMEIPOBSE 100 ESGBSE CarbonexBSE GreenexNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftyNIFTY Next 50NIFTY 100NIFTY 200NIFTY 500NIFTY MidCap 100NIFTY SmallCap 250NIFTY SmallCap 50NIFTY SmallCap 100NIFTY LargeMidCap 250NIFTY MidSmallCap 400NIFTY AutoNIFTY Consumer DurablesNIFTY FinanceNIFTY FMCGNIFTY MediaNIFTY MetalNIFTY PharmaNIFTY Private BankNIFTY PSU BankNIFTY RealtyNIFTY Oil & GasNIFTY SME EmergeNIFTY CommoditiesNIFTY CPSENIFTY EnergyNIFTY India ConsumptionNIFTY InfraNIFTY MNCNIFTY PSENIFTY Serv SectorNIFTY100 Liquid 15NIFTY Midcap Liquid 15NIFTY Midcap 150 Quality 50NIFTY50 Equal WeightNIFTY100 Equal WeightNIFTY100 Low Volatility 30NIFTY100 Alpha 30NIFTY Alpha 50NIFTY Dividend Opportunities 50NIFTY High Beta 50NIFTY Low Volatility 50NIFTY200 Quality 30NIFTY 500 Value 50NIFTY 100 Quality 30SECTORSAgricultureAirlinesAluminiumAsset Management CompaniesAutomobilesAuto AncillariesBanks (Private)Banks (PSU)BankingCementChemicalsDefenceDiagnosticsDronesEngineeringElectric VehicleElectric Vehicle BatteryEnergy SourcesESGEthanolFertilizersFintechFMCGFoodGreen HydrogenHotelsInfrastructureInsuranceInvestment and FinanceInvITIT (Large)IT (Others)LogisticsMediaMetalMiningIndia's Big Tech StocksIndian PharmaMNC PharmaPSUPaintPaperPlasticPowerRating AgenciesReal EstateREITsRenewable EnergyRetailingSemiconductorShippingSteelSugarSupply ChainTelecomTextilesTravel Support Services

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers